administering tirzepatide Compounded Weight Loss Program | GLP-1 Treatment Jonathan Q. Purnell, MD, PENS & Vials:40mg pen Pharmacist

administering tirzepatide Compounded Weight Loss Program | GLP-1 Treatment Jonathan Q. Purnell, MD, PENS & Vials:40mg pen Pharmacist

Jonathan Q. Purnell, MD, FTOS, coauthor of the joint expert guidance by The Obesity Society, Obesity Medicine Association, and Obesity Action Coalition, was featured in a Q&A on new obesity drug guidance.

The key difference lies in how these medications interrupt the weight gain cycle

Pharmacist

PENS & Vials:40mg pen

Patients in the STEP trials—the landmark weight-loss studies leading to semaglutide approval—ate normally before and after injections without compromising efficacy or safety